Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 15, 2022 9:00 A.M.
Form: S-3
CIK: 0001785345
Company Name: Landos Biopharma, Inc.
File Number: 333-263836